Log in to search using one of your social media accounts:
Gilead Versus Glaxo: See You In Court
The FDA approved a much-anticipated once-daily HIV medication from Gilead Sciences, ratcheting up its battle against GlaxoSmithKline for market share. Glaxo ’s response? A lawsuit.
Source: Forbes.com Healthcare News
Pharmaceuticals Authors: Johanna Bennett, Contributor Tags:
NASDAQ:GILD NYSE:GSK Source Type: